⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vaccinia virus

Every month we try and update this database with for vaccinia virus cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular CarcinomaNCT01171651
Carcinoma, Hepa...
JX-594 followed...
18 Years - SillaJen, Inc.
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsNCT00625456
Melanoma
Lung Cancer
Renal Cell Carc...
Squamous Cell C...
Recombinant Vac...
18 Years - SillaJen, Inc.
A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal CarcinomatosisNCT01443260
Peritoneal Carc...
GL-ONC1
18 Years - Genelux Corporation
Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaNCT01380600
Carcinoma, Colo...
Recombinant Vac...
18 Years - SillaJen, Inc.
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaNCT01394939
Colorectal Carc...
CRC
JX-594
Irinotecan
18 Years - SillaJen, Inc.
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid TumorsNCT03954067
Metastatic Canc...
Solid Tumors
Advanced Cancer
ASP9801
Pembrolizumab
18 Years - Astellas Pharma Inc
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)NCT05281471
Platinum-resist...
Platinum-refrac...
Fallopian Tube ...
Primary Periton...
High-grade Sero...
Endometrioid Ov...
Ovarian Clear C...
olvimulogene na...
Platinum chemot...
Non-platinum ch...
Bevacizumab (or...
18 Years - Genelux Corporation
Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid TumorsNCT00794131
Advanced Cancer...
GL-ONC1
18 Years - Genelux Corporation
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsNCT04725331
Metastatic Canc...
Soft Tissue Sar...
Merkel Cell Car...
Melanoma
Triple Negative...
Non Small Cell ...
BT-001
Pembrolizumab [...
18 Years - Transgene
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaNCT01394939
Colorectal Carc...
CRC
JX-594
Irinotecan
18 Years - SillaJen, Inc.
Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer OriginNCT02017678
Ovarian Cancer
JX-594
18 Years - Mount Sinai Hospital, Canada
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsNCT01169584
Neuroblastoma
Rhabdomyosarcom...
Lymphoma
Wilm's Tumor
Ewing's Sarcoma
Recombinant Vac...
2 Years - 21 YearsSillaJen, Inc.
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsNCT01169584
Neuroblastoma
Rhabdomyosarcom...
Lymphoma
Wilm's Tumor
Ewing's Sarcoma
Recombinant Vac...
2 Years - 21 YearsSillaJen, Inc.
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic CarcinomaNCT00629759
Neoplasms, Live...
JX-594: Recombi...
18 Years - Jennerex Biotherapeutics
GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerNCT02759588
Ovarian Cancer
Peritoneal Carc...
Fallopian Tube ...
GL-ONC1 alone, ...
21 Years - Genelux Corporation
Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-LactNCT05376527
Oncolytic Virot...
Double Recombin...
18 Years - "Oncostar" LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: